Precision for Medicine gains financing

Precision for Medicine Inc., a Chevy Chase-based company formed in 2012 to support new approaches to drug development and commercialization, said it secured $150 million in private equity financing to support acquisitions and development.

Leave a Reply

Your email address will not be published. Required fields are marked *